1. Structural Biology and Molecular Biophysics
Download icon

Regulatory switch at the cytoplasmic interface controls TRPV channel gating

  1. Lejla Zubcevic
  2. William F Borschel
  3. Allen L Hsu
  4. Mario J Borgnia
  5. Seok-Yong Lee  Is a corresponding author
  1. Duke University School of Medicine, United States
  2. National Institute of Environmental Health Sciences, National Institutes of Health, United States
Research Article
Cite this article as: eLife 2019;8:e47746 doi: 10.7554/eLife.47746
6 figures, 2 tables, 4 data sets and 1 additional file

Figures

Figure 1 with 1 supplement
The role of the cytoplasmic inter-protomer interface in hTRPV3 gating.

(A) Architecture of the hTRPV3 protomer. Ankyrin repeat domain (ARD) is colored in cyan, the coupling domain (CD) and its individual elements (HLHCD, βCD, Pre-S1CD) are colored in blue, transmembrane helices S1-S6 are colored in violet, the TRP domain is shown in magenta and the C-terminal domain (CTD) is colored in red. (B) A close-up view of the inter-protomer interface in hTRPV3. Residue K169 from the ARD and residues E751 and D752 from the CTD are shown in stick representation. Representative whole-cell current traces recorded at +60 mV from WT (C–D), K169A (E–F), and E751A (G–H) evoked by repeating applications 30 μM 2-APB for 15 s followed by 15 s of washout and corresponding time-course of use-dependent changes in the relative current amplitude. (I) Average current density from the first five 2-APB stimulations (WT: n = 13 biologically independent experiments; K169A: n = 10 biologically independent experiments; E751A: n = 6 biologically independent experiments). (J) Initial sensitization was characterized by the ratio of the response to 2-APB during the first (I0) and maximum current (Imax) response (Imax/I0) calculated as the mean from each biologically independent experiment. (WT: n = 13 biologically independent experiments; K169A: n = 10 biologically independent experiments; E751A: n = 7 biologically independent experiments).

https://doi.org/10.7554/eLife.47746.002
Figure 1—source data 1

This spreadsheet contains data points for the time course of 2-APB use-dependence plots in Figure 1D, 1F and 1H; current density data used to generate bar plots in Figure 1I; initial sensitization data used to generate bar plots in Figure 1J.

https://doi.org/10.7554/eLife.47746.004
Figure 1—figure supplement 1
State model and gating schemes of TRPV3 channels.

Simple state model of TRPV3 gating proposed by Liu et al. (2011). The transition rate from C1 → C0 (scheme 1) and O→C0 (scheme 2) is slow enough that this transition is irreversible. Both k0 and k1 transition rates are stimulant [s] dependent (heat or chemical agonist). Following removal of the stimulus, channels return to a closed intermediate state (C1) in scheme 1 or a new resting state (C1) in scheme 2. During consecutive stimulations, the occupancy of C1 increases, leading to greater sensitivity to the stimulus in a use-dependent manner.

https://doi.org/10.7554/eLife.47746.003
Figure 2 with 2 supplements
Rearrangements of the cytoplasmic domains in the TRPV3K169A structure.

(A) The cytoplasmic inter-protomer interface in TRPV3WT (left panel) and TRPV3K169A (right panel). The CTD and the putative N-terminal region are highlighted in red and purple, respectively. (B) Close-up view of the rearrangements in the cytoplasmic domains. In the TRPV3WT, the distal CTD (highlighted in red) coils around the βCD (highlighted in grey) (left panel). In the TRPV3K169A structure, the distal CTD undergoes a coil-to-helix transition (highlighted in red). An additional polypeptide density (highlighted in purple) is observed near the front of the βCD (highlighted in grey) and the proximal CTD, in the vicinity of the space occupied by the distal CTD coil in TRPV3WT and was assigned as a putative N-terminal domain from the neighboring protomer (NTD−1).

https://doi.org/10.7554/eLife.47746.005
Figure 2—figure supplement 1
Cryo-EM data collection and processing, TRPV3K169A.

(A) A representative micrograph from the TRPV3K169A data collection. (B) 3D reconstruction workflow. (C) Euler distribution plot. Red regions show the best represented views. (D) Local resolution estimate, calculated in Relion. (E) FSC curves calculated between the half maps (blue), atomic model and the full map (red) and between the model and each half-map (orange and green).

https://doi.org/10.7554/eLife.47746.006
Figure 2—figure supplement 2
Electron density in the TRPV3K169A cryo-EM map.

(A) Representative electron densities in the TRPV3K169A cryo-EM map. Densities are contoured at level 0.015 and radius 2. (B–C) Connectivity between the ARD and the putative N-terminal region. The unsharpened TRPV3K169A map is contoured at level 0.006.

https://doi.org/10.7554/eLife.47746.007
Figure 3 with 2 supplements
State-dependent changes at the cytoplasmic inter-protomer interface.

(A–B) Top view of the cytoplasmic inter-protomer interactions in TRPV3WT (A) and TRPV3K169A (B). In TRPV3WT the CTD (red) coils around the βCD (grey). The distal CTD interacts with the ARD at the front of the interface and with the loop of ankyrin repeat 5 (AR5, magenta) at the back. In TRPV3K169A, the interface is changed due to the coil-to-helix transition in the distal CTD, which no longer participates in the interactions at the front of the interface and forms tighter interactions with AR5. The front of the interface is now occupied by the putative NTD (yellow). (C) A close-up view from the cytoplasmic cavity of the interactions between the distal CTD (red surface representation) and AR5 (magenta surface representation) in TRPV3WT. Residue W739 forms a cation-π interaction with the amino group of Q313 (dashed line). (D) The coil-to-helix transition changes the conformation of the AR5 loop. In TRPV3K169A, the W739-Q313 interaction is broken. Residues K742 and W743, which in TRPV3WT are not within interaction distances with the rest of the protein, form interactions with the backbone of E308 in AR5 and P384 in βCD, respectively (dashed lines). Representative whole-cell current traces recorded at +60 mV from W739A (E), W742A (F), and K743A (G) evoked by repeating applications 30 μM 2-APB for 15 s followed by 15 s of washout. (H) Average current density for the first five 2-APB stimulations (W739A: n = 6 biologically independent experiments; W742A: n = 6 biologically independent experiments; K743A: n = 5 biologically independent experiments). (I) Ratio of first (I0) and maximum current (Imax) 2-APB stimulation (Imax/I0) as in (G), calculated as the mean from each biologically independent experiment (W739A: n = 6 biologically independent experiments). (J) Mean 2-APB EC50 from three consecutive dose-response rounds fit with the Hill equation (WT: n = 5 biologically independent experiments; W742A: n = 5 biologically independent experiments; K743A: n = 4 biologically independent experiments). See Figure 3—figure supplement 2 for representative current traces and dose–response relationship fit with the Hill equation.

https://doi.org/10.7554/eLife.47746.009
Figure 3—source data 1

This spreadsheet contains current density data used to generate bar plots in Figure 3H; initial sensitization data used to generate bar plots in Figure 3I; calculated dose-response values used to generate bar plots in Figure 3J.

https://doi.org/10.7554/eLife.47746.013
Figure 3—figure supplement 1
Conformational changes in the cytoplasmic domains in TRPV3K169A.

(A) Overlay of the tetrameric cytoplasmic assemblies from TRPV3WT (orange) and TRPV3K169A (blue). Close-up view single ARD shows that the tetrameric assemblies cannot be superposed through a rigid body rotation. (B) Individual ARDs, not attached to the tetrameric assembly, from TRPV3WT (orange) and TRPV3K169A (blue) can be superposed. (C) In the TRPV3WT (orange, bottom) structure there is no coupling between the AR5 (magenta) and the HLHCD (orange). However, in TRPV3K169A (blue, top) upon coil-to-helix transition in the distal CTD (red), the CTD-AR5 (magenta) interaction forces a change in conformation in the loop of AR5, bringing it within interaction distance of HLHCD (orange). (D) Surface representation of the overlay between single protomers of TRPV3WT (orange cartoon, gray surface) and TRPV3K169A (blue cartoon, blue surface). The overlay shows that the TM domains overlay well, while the cytoplasmic domains exhibit substantial differences. The cytoplasmic assembly of TRPV3K169A (right panel) swivels, so that the N-terminal part is lifted up toward the membrane while the C-terminal part is lowered into the cytosol. The line drawn between the tip of the βCD and residue A110 in AR1 indicates the relative movement within the cytoplasmic assembly.

https://doi.org/10.7554/eLife.47746.010
Figure 3—figure supplement 2
The TRPV3 W742A and K743A CTD mutants alter hysteresis.

Three consecutive rounds of 2-APB dose-responses (0 (black) 3(purple), 10 (blue), 30 (green), 50 (yellow), 100 (orange), 300 (red) μM) was applied for 15 s followed 15 s of wash for WT (A) W742A (B) and K743A (C) at +60 mV. (D) Averaged dose-response of WT, W742A, and K743A from the first (square), second (circle), and third (triangle) consecutive dose-response round. Inset is EC50 and hill coefficient (nH) fitted to the average normalized current at each 2-APB concentration per round (WT: n = 5 biologically independent experiments; W742A: n = 5 biologically independent experiments; K743AA: n = 4 biologically independent experiments).

https://doi.org/10.7554/eLife.47746.011
Figure 3—figure supplement 2—source data 1

This spreadsheet contains dose-response data used to calculate mean values plotted in Figure 3—figure supplement 2D.

https://doi.org/10.7554/eLife.47746.012
Figure 4 with 7 supplements
The structure of TRPV3K169A 2-APB exhibits changes in both transmembrane and cytoplasmic domains.

(A) One 2-APB molecule is bound to each protomer of the TRPV3K169A 2-APB channel (magenta). 2-APB is found between the HLHCD, Pre-S1CD and TRP domains in a binding site defined by residues H417 in the HLHCD, H426, H430, W433 in the Pre-S1CD and W692, R693 and R696 in the TRP domain. All residues are shown in stick and red sphere representation. 2-APB is shown in stick and cyan sphere representation. (B) The S6 helix of TRPV3K169A (blue) undergoes an α-to-π transition in the presence of 2-APB (magenta). (C) The α-to-π transition tightens the connection between S6 and the TRP domain. In the TRPV3WT structure (orange), the TRP domain and the S6 are connected via a loop, but in the TRPV3K169A 2-APB channel (magenta) the TRP domain and S6 form a continuous helical structure. In addition, the TRP domain exhibits a swivel in the TRPV3K169A 2-APB structure. (D–E) The coil-to-helix transition in TRPV3K169A 2-APB increases coupling between the cytoplasmic domains and the TRP domain. In the TRPV3WT structure (orange) (D), the loop of AR5 (magenta surface) does not interact with the HLHCD (orange surface). However, in TRPV3K169A 2-APB (magenta) (E) the coil-to-helix transition in the distal CTD induces a conformational change in the loop of AR5 (magenta surface), coupling it to the HLHCD (orange surface) and the TRP domain (light blue surface). 2-APB (cyan stick and surface representation) contributes to increased interactions between the TRP domain and Pre-S1CD.

https://doi.org/10.7554/eLife.47746.014
Figure 4—figure supplement 1
Cryo-EM data collection and processing, TRPV3K169A 2-APB.

(A) A representative micrograph from TRPV3K169A 2-APB data collection. (B) 3D reconstruction workflow. (C) Euler distribution plot. Red regions show the most represented views. (D) Local resolution estimate, calculated in Relion. (E) FSC curves calculated between the half maps (blue), atomic model and the full map (red) and between the model and each half-map (orange and green).

https://doi.org/10.7554/eLife.47746.015
Figure 4—figure supplement 2
Electron density in the TRPV3K169A 2-APB cryo-EM map.

Representative electron densities in the TRPV3K169A 2-APB cryo-EM map. Densities are contoured at level 0.03 and radius 2. The inset in the S6 panel shows a close-up of the density around the π-helical turn contoured at level 0.02 and radius 2. The black solid lines represent the H-bonds in the α-helix, which are broken in the π-helical turn.

https://doi.org/10.7554/eLife.47746.016
Figure 4—figure supplement 3
Comparison of the pore conformations of hTRPV3WT, hTRPV3K169A 2-APB and mTRPV3Open.

Bottom-up view of the hTRPV3WT (PDB ID 6MHO, orange), hTRPV3K169A 2-APB (magenta) and mTRPV3Open (PDB ID 6DVZ, green) pores. The conformation of hTRPV3K169A 2-APB resembles that of the mTRPV3Open (Overlay).

https://doi.org/10.7554/eLife.47746.017
Figure 4—figure supplement 4
Coupling between the cytoplasmic and transmembrane domains.

(A) Top view of the coupling between the TRP domain (light blue), the CD (orange, Pre-S1CD and HLHCD) and the AR5 (magenta) in TRPV3WT. (B) In the TRPV3K169A 2-APB structure, the coil-to-helix transition in the CTD forces the loop AR5 to change conformation (magenta) and interact with HLHCD (orange). This induces a swivel in the CD (orange) and the TRP domain (light blue). 2-APB (cyan spheres) further increases the coupling between the CD and the TRP domain. (C–E) Electron density around the CTD, AR5, CD and TRP domain in TRPV3WT (C), TRPV3K169A (D) and TRPV3K169A 2APB (E) viewed from inside of the cytoplasmic vestibule. The density is contoured at level 0.02 in TRPV3WT, 0.01 in TRPV3K169A and 0.02 in TRPV3K169A 2-APB.

https://doi.org/10.7554/eLife.47746.018
Figure 4—figure supplement 5
The CTD in thermoTRPV structures.

(A) The cryo-EM map (EMD-8921) and atomic structure of the open mTRPV3 (PDB 6DVZ). Close-up view shows the fit of the CTD region into the electron density. (B) hTRPV3K169A 2-APB fit into the cryo-EM map of the open mTRPV3 (EMD-8921). Close-up view shows that the electron density can more feasibly be built as a helix. (C) The cryo-EM map (EMD-9115) and atomic structure of the hTRPV3 apo, closed state (PDB ID 6MHO). (D) The X-ray crystallographic electron density and atomic structure of the apo closed rabbit TRPV2 (PDB ID 6BWM). (E) The cryo-EM map (EMD-5778) and atomic structure of the apo, closed rTRPV1 (PDB ID 3J5P). (F) hTRPV3K169A 2-APB fit into the cryo-EM map of the open apo, closed rTRPV1 (EMD-5778).

https://doi.org/10.7554/eLife.47746.019
Figure 4—figure supplement 6
APB binding in TRPV3K169A 2APB.

(A) Non-assigned densities (red) in the VSLD cavity of TRPV3K169A (green, left) and TRPV3K169A 2-APB (purple, right). Electron densities are contoured at levels 0.015 and 0.03, respectively. (B) No electron density is present at the proposed third 2-APB binding site at the extracellular side of the VSLD (arrow). Electron density is contoured at level 0.03. (C) Binding of 2-APB (red stick representation) between the TRP domain (yellow) and Pre-S1CD (green) in TRPV3K169A 2-APB half-map 1 (magenta, contoured at 0.0175), half-map 2 (yellow, contoured at 0.0175) and full map (blue, contoured at 0.03).

https://doi.org/10.7554/eLife.47746.020
Figure 4—figure supplement 7
APB and camphor response of proposed 2-APB binding site mutants.

(A) Graphical representation of the current response ratio of sub- (30 μM) and saturating 2-APB (300 μM) to camphor (10 mM) calculated as the mean from each biologically independent experiment. (WT: n = 5 biologically independent experiments; R487A: n = 4 biologically independent experiments; R487W: n = 4 biologically independent experiments; Y540W: n = 4 biologically independent experiments; E501G: n = 4 biologically independent experiments; Y540A: n = 4 biologically independent experiments; Y565A: n = 4 biologically independent experiments; H426A: n = 5 biologically independent experiments;). (B) Representative voltage ramp (−60 to +60 mV, 400 ms) traces to wash (gray), 30 (green) and 300 (red) μM 2-APB, and 10 mM camphor (blue). Only H426A possessed a lower 2-APB to camphor ratio compared to WT channels. (C) Protomer of mouse TRPV3 Y654A mutant bound to 2-APB (PDB ID 6DVZ) with three proposed binding sites highlighted (dotted boxes) (Singh et al., 2018). Mutated residues are shown in stick and sphere representation.

https://doi.org/10.7554/eLife.47746.021
Figure 4—figure supplement 7—source data 1

This spreadsheet contains data used to calculate the mean 2-APB to camphor ratio values plotted in Figure 4—figure supplement 7A.

https://doi.org/10.7554/eLife.47746.022
Figure 5 with 1 supplement
Parallels between TRPV3K169A and wild-type TRPV1.

(A) Representative whole-cell recording at +60 mV of WT (black), K169A (red), E751A (blue), W739A (orange) immediately following 2-APB sensitization protocol, with perfusion protocol of 5 s wash, followed by 15 s 30 μM 2-APB, prolonged 30 s wash and the residual current was blocked by 5 s application of 50 μM ruthenium red (RuR). The scale bars units are in current density (pA/pF). (B) Graphical representation of RuR sensitive residual current at the end of the recording in (A) (WT: n = 10 biologically independent experiments; K169A: n = 5 biologically independent experiments; E751A: n = 6 biologically independent experiments, W739A: n = 5 biologically independent experiments). (C) Basal current activity before application of ligand was determined by the blocking the current following a voltage step from 0 to +60 mV with 50 μM RuR. (D) Graphical representation of the mean blocked current density from the protocol in (C) (GFP control: n = 5 biologically independent experiments; WT: n = 6 biologically independent experiments; K169A: n = 5 biologically independent experiments; E751A: n = 5 biologically independent experiments, W739A: n = 6 biologically independent experiments). (E) Conductance voltage relation of WT, K169A, and E751A in the absence of ligand determined from peak tail current elicited from a −160 mV post step pulse following a voltage step between −120 to +200 mV (Δ 20 mV). The conductance of both mutants fail to saturate at +200 mV while WT channels are nonconductive at the tested voltages (WT: n = 3 biologically independent experiments; K169A: n = 3 biologically independent experiments; E751A: n = 3 biologically independent experiments). (F) Alignment of AR5 from TRPV3WT (orange), TRPV3K169A 2APB (magenta) and TRPV1 (light cyan). The AR5 loop of TRPV1 assumes a conformation similar to that of TRPV3K169A 2APB. (G) The AR5 loop and the HLHCD are within interaction distance in TRPV1.

https://doi.org/10.7554/eLife.47746.023
Figure 5—source data 1

This spreadsheet contains the data used to calculate the ruthenium red sensitive current plots in Figure 5B and 5D; voltage step data used to calculate conductance plot in Figure 5E.

https://doi.org/10.7554/eLife.47746.025
Figure 5—figure supplement 1
Sequence alignment of rat TRPV1 (rTRPV), rabbit TRPV2 (rabTRPV2), human TRPV3 (hTRPV3) and xenopus TRPV4 (xTRPV4).

The alignment is colored by conservation and regions of interest are marked with purple lines. residues of interest are indicated with *. The distal CTD has a high helical propensity as calculated by PsiPred. Indicated by a helix cartoon. Abbreviations: ARD, ankyrin repeat domain; AR2, ankyrin repeat 2; AR5, ankyrin repeat 5; βCD, β-sheet of the coupling domain (CD); HLH CD, helix-loop-helix of the CD; Pre-S1 CD, Pre-S1 of the CD; PH, pore helix; SF, selectivity filter; PL, pore loop.

https://doi.org/10.7554/eLife.47746.024
The CTD-mediated ‘switch’ gating mechanism.

In the naive closed state (C0), the distal CTD is stretched around the βCD via a salt bridge ‘hook’ interaction with the ARD and the switch is ‘off’. When the CTD is ‘unhooked’ from the ARD, it undergoes a coil-to-helix transition (the switch turns ‘on’) which leads to a conformational change in the loop of AR5 and consequently to increased coupling between the cytoplasmic and transmembrane domains, which is prerequisite for channel opening (C1).

https://doi.org/10.7554/eLife.47746.026

Tables

Table 1
Cryo-EM data collection, refinement and validation statistics
https://doi.org/10.7554/eLife.47746.008
TRPV3K169A
(EMD-20192)
(PDB 6OT2)
TRPV3K169A 2-APB
(EMD-20194)
(PDB 6OT5)
Data collection and processing
Magnification130,000x75,000x
Voltage (kV)300300
Electron exposure (e–/Å2)4042
Defocus range (μm)1–2.51.25–3
Pixel size (Å)1.061.08
Symmetry imposedC4C4
Initial particle images (no.)452,3881,174,521
Final particle images (no.)95,18479,006
Map resolution (Å)4.13.6
FSC threshold0.1430.143
Refinement
Initial model used (PDB code)6MHO6MHO
Model resolution (Å)4.13.6
FSC threshold0.1430.143
Map sharpening B factor (Å2)−120−100
Model composition
Non-hydrogen atoms17,33217,800
Protein residues25002492
Ligands04 (2-APB)
B factors (Å2)
Protein87.4340.51
Ligandn/a35.66
R.m.s. deviations
Bond lengths (Å)0.0080.008
Bond angles (°)0.8680.833
MolProbity score1.641.24
Clashscore55
Poor rotamers (%)00
Ramachandran plot
Favored (%)92.7097.01
Allowed (%)7.302.99
 Disallowed (%)00
Key resources table
Reagent type
(species) or
resource
DesignationSource or referenceIdentifiersAdditional information
Cell line
(E. coli)
DH10BacThermoFisher Scientific10361012
Cell line
(Spodoptera frugiperda)
Sf9ATCCCRL-1711RRID:CVCL_0549
Cell line
(Homo sapiens)
HEK293TATCCCRL-11268; Lot
Number 62312975
RRID:CVCL_0063
Cell media
component
Dulbecco’s Modified
Eagle’s Medium (DMEM)
- low glucose
Gibco11885–084
Cell media
component
Heat Inactivated
Fetal Bovine Serum
Gibco10082–139
Cell media
component
Anti-Anti
(Antibiotic-Antiycotic)
Gibco15240–062
Recombinant
DNA reagent
human TRPV3GenscriptPubmed
Gene ID: 162514
Recombinant
DNA reagent
Bac-to-Bac
Baculovirus
Expression System
ThermoFisher Scientific10359016
Recombinant
DNA reagent
FuGene6PromegaE2691
Chemical
compound, drug
n-dodecyl-β-d-
maltopyranoside(DDM)
AnatraceD310
Chemical
compound, drug
Cholesteryl
Hemisuccinate
AnatraceCH210
Chemical
compound, drug
PMAL-C8AnatraceP5008
Chemical
compound, drug
TRISFisher ScientificBP152
Chemical
compound, drug
NaClFisher ScientificS271
Chemical
compound, drug
CaCl2Fisher ScientificC70
Chemical
compound, drug
KClSigma AldrichP9333
Chemical
compound, drug
MgCl2Sigma AldrichM8266
Chemical
compound, drug
4-(2-hydroxyethyl)−1-
piperazineethanesulfonic
acid (HEPES)
Sigma AldrichH3375
Chemical
compound, drug
NaOHSigma AldrichS5881
Chemical
compound, drug
CsClSigma AldrichC3139
Chemical
compound, drug
Ethylene glycol-bis
(2-aminoethylether)-
N,N,N′,N′-tetraacetic
acid (EGTA)
Sigma AldrichE4378
Chemical
compound, drug
CsOH solutionSigma Aldrich232041
Chemical
compound, drug
2-Aminoethyl
diphenylborinate
(2-APB)
Sigma AldrichD9754
Chemical
compound, drug
D-CamphorSigma AldrichW223018
Chemical
compound, drug
Dimethyl sulfoxide
(DMSO)
Sigma AldrichD2650
Chemical
compound, drug
leupeptinGoldBioL-010
Chemical
compound, drug
pepstatinGoldBioP-020
Chemical
compound, drug
aprotininGoldBioA-655
Chemical
compound, drug
DNase IGoldBioD-301
Chemical
compound, drug
β-mercapto ethanolSigma AldrichM3148
Chemical
compound, drug
PMSFSigma AldrichP7626
Chemical
compound, drug
anti-FLAG resinSigma AldrichA4596
Chemical
compound, drug
Bio-Beads SM-2BioRad152–8920
Chemical
compound, drug
1-palmitoyl-2-oleoyl
-sn-glycero-3-phosphocholine
(POPC)
Avanti Polar Lipids850457C
Chemical
compound, drug
1-palmitoyl-2-oleoyl
-sn-glycero-3-
phosphoethanolamine
(POPE)
Avanti Polar Lipids850757C
Chemical
compound, drug
1-palmitoyl-2-oleoyl
-sn-glycero-3-phospho-
(1'-rac-glycerol) (POPG)
Avanti Polar Lipids840457C
Software,
algorithm
MotionCor2Zheng et al., 2017http://msg.ucsf.edu/em/software/motioncor2.htmlRRID:SCR_016499
Software,
algorithm
GCTFZhang, 2016https://www.mrc-lmb.cam.ac.uk/kzhang/RRID:SCR_016500
Software,
algorithm
RELION 3.0Zivanov et al., 2018https://www2.mrc-lmb.cam.ac.uk/relion/RRID:SCR_016274
Software,
algorithm
CootEmsley and Cowtan, 2004https://www2.mrc-lmb.cam.ac.uk/personal/pemsley/coot/RRID:SCR_014222
Software,
algorithm
PhenixAdams et al., 2010http://phenix-online.org/RRID:SCR_014224
Software,
algorithm
MolprobityChen et al., 2010http://molprobity.biochem.duke.edu/index.phpRRID:SCR_014226
Software,
algorithm
UCSF ChimeraPettersen et al., 2004https://www.cgl.ucsf.edu/chimera/RRID:SCR_004097
Software,
algorithm
PymolShrödinger LLChttps://pymol.org/2/RRID:SCR_000305
Software,
algorithm
pClamp10Molecular DevicesRRID:SCR_011323
Software,
algorithm
OriginPro 2016OriginLab Corp.RRID:SCR_014212
Software,
algorithm
Microsoft Excel 2010MicrosoftRRID:SCR_016137
otherWhatman No. one
filter paper
Sigma AldrichWHA1001325
OtherUltrAuFoil R1.2/1.3
300-mesh grid
Electron Microscopy
Sciences
Q350AR13A
OtherCryo-electron microscopy
structure of the human
TRPV3 channel
Zubcevic et al., 2018aPDB ID 6MHOZubcevic et al., 2018b
OtherCryo-electron microscopy
structure of the human
TRPV3 channel
Zubcevic et al., 2018aEMDB ID EMD-9115Zubcevic et al., 2018b

Data availability

Cryo-EM data and structural models are deposited in the EMDB and RCSB, respectively with the following codes: EMD-20192, PDB: 6OT2 and EMD-20194, PDB: 6OT5

The following data sets were generated
  1. 1
    Electron Microscopy Data Bank
    1. L Zubcevic
    2. F Borschel William
    3. L Hsu Allen
    4. J Borgnia Mario
    5. S-Y Lee
    (2019)
    ID EMD-20194. Structure of the TRPV3 K169A sensitized mutant in the presence of 2-APB at 3.6 A resolution.
  2. 2
    Protien Data Bank
    1. L Zubcevic
    2. F Borschel William
    3. L Hsu Allen
    4. J Borgnia Mario
    5. S-Y Lee
    (2019)
    ID 6OT5. Structure of the TRPV3 K169A sensitized mutant in the presence of 2-APB at 3.6 A resolution.
  3. 3
    Electron Microscopy Data Bank
    1. L Zubcevic
    2. F Borschel William
    3. L Hsu Allen
    4. J Borgnia Mario
    5. S-Y Lee
    (2019)
    ID EMD-20192. Structure of the TRPV3 K169A sensitized mutant in apo form at 4.1 A resolution.
  4. 4
    Protein Data Bank
    1. L Zubcevic
    2. F Borschel William
    3. L Hsu Allen
    4. J Borgnia Mario
    5. S-Y Lee
    (2019)
    ID 6OT2. Structure of the TRPV3 K169A sensitized mutant in apo form at 4.1 A resolution.

Additional files

Download links

A two-part list of links to download the article, or parts of the article, in various formats.

Downloads (link to download the article as PDF)

Download citations (links to download the citations from this article in formats compatible with various reference manager tools)

Open citations (links to open the citations from this article in various online reference manager services)